Literature DB >> 20431569

Teaching old receptors new tricks: biasing seven-transmembrane receptors.

Sudarshan Rajagopal1, Keshava Rajagopal, Robert J Lefkowitz.   

Abstract

Seven-transmembrane receptors (7TMRs; also known as G protein-coupled receptors) are the largest class of receptors in the human genome and are common targets for therapeutics. Originally identified as mediators of 7TMR desensitization, beta-arrestins (arrestin 2 and arrestin 3) are now recognized as true adaptor proteins that transduce signals to multiple effector pathways. Signalling that is mediated by beta-arrestins has distinct biochemical and functional consequences from those mediated by G proteins, and several biased ligands and receptors have been identified that preferentially signal through either G protein- or beta-arrestin-mediated pathways. These ligands are not only useful tools for investigating the biochemistry of 7TMR signalling, they also have the potential to be developed into new classes of therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431569      PMCID: PMC2902265          DOI: 10.1038/nrd3024

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  117 in total

1.  Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery.

Authors:  L M Bohn; L A Dykstra; R J Lefkowitz; M G Caron; L S Barak
Journal:  Mol Pharmacol       Date:  2004-07       Impact factor: 4.436

Review 2.  Desensitization of G protein-coupled receptors and neuronal functions.

Authors:  Raul R Gainetdinov; Richard T Premont; Laura M Bohn; Robert J Lefkowitz; Marc G Caron
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

3.  Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.

Authors:  Seungkirl Ahn; Sudha K Shenoy; Huijun Wei; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2004-06-17       Impact factor: 5.157

4.  Historical review: a brief history and personal retrospective of seven-transmembrane receptors.

Authors:  Robert J Lefkowitz
Journal:  Trends Pharmacol Sci       Date:  2004-08       Impact factor: 14.819

5.  Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments.

Authors:  U Wilden; S W Hall; H Kühn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Light-dependent phosphorylation of rhodopsin. Purification and properties of rhodopsin kinase.

Authors:  H Shichi; R L Somers
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

7.  Light-dependent phosphorylation of rhodopsin: number of phosphorylation sites.

Authors:  U Wilden; H Kühn
Journal:  Biochemistry       Date:  1982-06-08       Impact factor: 3.162

8.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor.

Authors:  A De Lean; J M Stadel; R J Lefkowitz
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

9.  Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.

Authors:  A Enjalbert; J Bockaert
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

10.  Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase is associated with phosphorylation of the beta-adrenergic receptor.

Authors:  J M Stadel; P Nambi; R G Shorr; D F Sawyer; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  365 in total

1.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium.

Authors:  Rahima Zennadi; Erin J Whalen; Erik J Soderblom; Susan C Alexander; J Will Thompson; Laura G Dubois; M Arthur Moseley; Marilyn J Telen
Journal:  Blood       Date:  2011-12-06       Impact factor: 22.113

3.  A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells.

Authors:  Hiroshi Yagi; Wenfu Tan; Patricia Dillenburg-Pilla; Sylvain Armando; Panomwat Amornphimoltham; May Simaan; Roberto Weigert; Alfredo A Molinolo; Michel Bouvier; J Silvio Gutkind
Journal:  Sci Signal       Date:  2011-09-20       Impact factor: 8.192

4.  Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41).

Authors:  Ikuo Kimura; Daisuke Inoue; Takeshi Maeda; Takafumi Hara; Atsuhiko Ichimura; Satoshi Miyauchi; Makio Kobayashi; Akira Hirasawa; Gozoh Tsujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

5.  Desipramine selectively potentiates norepinephrine-elicited ERK1/2 activation through the α2A adrenergic receptor.

Authors:  Christopher Cottingham; Adrian Jones; Qin Wang
Journal:  Biochem Biophys Res Commun       Date:  2012-03-03       Impact factor: 3.575

Review 6.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 7.  Probing heterotrimeric G protein activation: applications to biased ligands.

Authors:  Colette Denis; Aude Saulière; Segolene Galandrin; Jean-Michel Sénard; Céline Galés
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 8.  Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Shyamal K Goswami; Sathyamangla V Naga Prasad
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

9.  Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation.

Authors:  Geneviève Oligny-Longpré; Maithé Corbani; Joris Zhou; Mireille Hogue; Gilles Guillon; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

Review 10.  Modelling three-dimensional protein structures for applications in drug design.

Authors:  Tobias Schmidt; Andreas Bergner; Torsten Schwede
Journal:  Drug Discov Today       Date:  2013-11-08       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.